Regulation of PD-L1 expression in non–small cell lung cancer by interleukin-1β

INTRODUCTION: Programmed cell death–ligand 1 (PD-L1) is a biomarker for prediction of the clinical efficacy of immune checkpoint inhibitors in various cancer types. The role of cytokines in regulation of PD-L1 expression in tumor cells has not been fully characterized, however. Here we show that int...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayama, Aiko, Tanaka, Kentaro, Tsutsumi, Hirono, Nakanishi, Takayuki, Yamashita, Sho, Mizusaki, Shun, Ishii, Yumiko, Ota, Keiichi, Yoneshima, Yasuto, Iwama, Eiji, Okamoto, Isamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333574/
https://www.ncbi.nlm.nih.gov/pubmed/37441079
http://dx.doi.org/10.3389/fimmu.2023.1192861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333574/
https://www.ncbi.nlm.nih.gov/pubmed/37441079
http://dx.doi.org/10.3389/fimmu.2023.1192861

Ejemplares similares